Legend Biotech
LEGN
LEGN
198 hedge funds and large institutions have $5.78B invested in Legend Biotech in 2023 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 72 increasing their positions, 69 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $5.81B → $5.78B (-$37.8M)
8% less call options, than puts
Call options by funds: $16.9M | Put options by funds: $18.4M
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Holders
198
Holding in Top 10
8
Calls
$16.9M
Puts
$18.4M
Top Buyers
| 1 | +$57.8M | |
| 2 | +$46.8M | |
| 3 | +$44.5M | |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$30.4M |
| 5 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$27.4M |
Top Sellers
| 1 | -$76.6M | |
| 2 | -$33.8M | |
| 3 | -$22.8M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$21.1M |
| 5 |
Millennium Management
New York
|
-$16.5M |